January 26, 2022
This research, led by Jean Cook, PhD, and Liu Mei, PhD, at the UNC School of Medicine, may help explain why certain parts of the genome become highly mutable in some cancers.
January 25, 2022
The record-setting gift supports development of innovative cancer treatments, eradicating health disparities. The center's inaugural director is Lisa Carey, PhD, the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research.
January 20, 2022
The UNC Medical Center is the only organization in North Carolina accredited by the Commission on Cancer’s National Accreditation Program for Rectal Cancer.
December 23, 2021
Jenny Ting, PhD, is the recipient of the Illinois State University Distinguished Alumni Award for her outstanding immunology research.
December 15, 2021
The Eshelman Institute for Innovation recently opened its pre-proposal application for the 2022 annual grant cycle. The Institute seeks to fund translational research related to therapeutics focused on oncology, infectious disease, and neuroscience, including rare diseases, and all digital health technologies. The Institute also welcomes ideas for devices and diagnostics, and other therapeutic areas and services.
October 6, 2021
Rich Preyer and Marilyn Jacobs Preyer of Hillsborough, North Carolina, have donated $1 million to support the latest phase of UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study.
September 29, 2021
Chemtai Mungo, MD, MPH, has been appointed as a UNC WRHR Scholar. Her primary research is focused on increasing access to cervical cancer prevention in low-income countries.
September 23, 2021
Hongwei Du, PhD, and Gianpietro Dotti, MD, published research in Nature Cancer showing that a dual-threat CAR-T immunotherapy was effective in animal models of neuroblastoma, a nerve cell cancer.
September 14, 2021
The UNC Lineberger Developmental Funding Program supports the development of cancer research led by faculty to stimulate new applications for extramural funding. All UNC Lineberger Comprehensive Cancer Center members, UNC-Chapel Hill faculty, and UNC system school faculty are encouraged to apply. Available targeted RFAs for the Fall 2021 cycle: (1) Cancer Survivorship Research, (2) Cancer Screening, (3) Population Sciences Approach to Addressing Cancer Disparities in North Carolina
August 4, 2021
Tonia Poteat, PhD, MPH, a core member of the Center for Health Equity Research, and colleagues published research on delays in breast cancer care by race and sexual orientation.
July 12, 2021
Lisa Carey, MD, member of the UNC Lineberger Comprehensive Cancer Center, discusses the clinical implications of the phase 3 FeDeriCa trial in HER2-positive breast cancer.
February 9, 2021
Dr. Rumey Ishizawar, Medical Director of the UNC Rheumatology Clinic, founded the multi-disciplinary UNC Immuno-Oncology Group (IOG) in 2017 to optimize clinical management of cancer patients who develop immune related adverse events (irAEs).